Skip to content
OpenCapital
Get started

Crinetics Pharmaceuticals CRNX Enterprise value

Enterprise value at other companies

Neurocrine Biosciences logo
Neurocrine BiosciencesNBIX
$13.41B+18.5%
Corcept Therapeutics logo
Corcept TherapeuticsCORT
$4.19B-65.0%
Viking Therapeutics logo
Viking TherapeuticsVKTX
$3.81B-14.5%
Catalyst Pharmaceutical logo
Catalyst PharmaceuticalCPRX
$2.27B-4.1%
Amneal Pharmaceuticals, Inc. logo
Amneal Pharmaceuticals, Inc.AMRX
$6.34B+33.4%
Rhythm Pharmaceuticals, Inc. logo
Rhythm Pharmaceuticals, Inc.RYTM
$5.99B+78.4%

Other financials

Income statement

See full
Revenue$10.7M+2,873%
Gross profit$10.5M+2,818%
Operating income-$140.4M-26.0%
Net income-$127.8M-32.1%
EPS (diluted)-$1.23-18.3%

Balance sheet

See full
Cash & equivalents$115.1M+20.1%
Total debt$47.9M-5.8%
Total equity$1.3B+2.1%
Total assets$1.4B+2.9%

Cash flow

See full
Operating cash flow-$124.7M-41.0%
CapEx$820.0K-33.8%
Free cash flow-$125.5M-40.0%

Valuation

See full
Market cap$3.78B+21.9%
P/S209.3×-3,875×

Profitability

See full
Gross margin150%-15.6pp
Operating margin-3,020.3%-1,463pp
Net margin-2,747.2%-1,328pp
FCF margin-2,321.7%-1,122pp

Returns & leverage

See full
Return on equity-39.2%+14.5pp
Debt / equity0×0.0×
Current ratio18.6×-3.9×

Where this comes from

Calculated from Crinetics Pharmaceuticals’s reported figures.

$3.8Bmarket cap+$47.9Mtotal debt−$115.1Mcash and equivalents=$3.74B

The official record: Crinetics Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Crinetics Pharmaceuticals's enterprise value.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Crinetics Pharmaceuticals's enterprise value?
Crinetics Pharmaceuticals (CRNX) reported enterprise value of $3.74B in Q1 2026.
How has Crinetics Pharmaceuticals's enterprise value changed year-over-year?
Crinetics Pharmaceuticals's enterprise value increased by 21.5% year-over-year, from $3.08B to $3.74B.
What is the long-term trend for Crinetics Pharmaceuticals's enterprise value?
Over 5 years (2020 to 2025), Crinetics Pharmaceuticals's enterprise value has grown at a 49.6% compound annual growth rate (CAGR), from $581.99M to $4.36B.
What does enterprise value mean?
Market capitalization plus total debt minus cash, at the quarter end. The cost to acquire the whole business — what an buyer pays for equity and debt, net of the cash they'd inherit.